Atropine role in the pharmacological erection test: Study of 228 patients

Journal of Urology

Volumn 158, Issue 5, 1997, Pages 1760-1763

  Sogari, Paulo Roberto ^a   Telöken, Cláudio ^a   Souto, Carlos Ary Vargas ^a  

^a Department of Urology ^*  (Brazil)

Author keywords

Alprostadel; Atropine; Impotence; Papaverine; Phentolamine

Indexed keywords

ADRENALIN; ATROPINE; PAPAVERINE; PHENTOLAMINE MESYLATE; PROSTAGLANDIN E1; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG MIXTURE; HUMAN; IMPOTENCE; INTRACAVERNOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 0343580468     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64122-3     Document Type: Article

References (30)

1. Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J. and McKinlay, J. B.: Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J. Urol., 151: 54, 1994.
2. Carrier, S., Brock, G., Kour, N. W. and Lue, T. F.: Pathophysiology of erectile dysfunction. Urology, 42: 468, 1993.
3. Sarosdy, M. F., Hudnall, C. H., Erickson, D. R., Hardin, T. C. and Novicki, D. E.: A prospective double-blind trail of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence. J. Urol., 141: 551, 1989.
4. Earle, C. M., Keogh, E. J., Wisniewski, Z. S., Tulloch, A. G. S., Lord, D. J., Watters, G. R. and Glatthaar, C.: Prostaglandin E1 therapy for impotence, comparison with papaverine. J. Urol., 143: 57, 1990.
5. Chiang, H-S., Wen, T.-C., Wu, C.-C. and Chiang, W.-H.: Prostaglandin E1 versus papaverine for diagnosis of erectile dysfunction. Int. J. Impotence Res., suppl, 23: 127, 1990.
6. Chen, J. K., Hwang, T. I. and Yang, C. R.: Comparison of effects following the intracorporeal injection of papaverine and prostaglandin E1. Brit. J. Urol., 69: 404, 1992.
7. Hall, S., Honing, S. C., Payton, T. R., Krane, R. J. and Goldstein, I.: Use of atropine sulfate in pharmacologic erections: initial experience with one year follow-up in the United States. J. Urol., part 2, 147: 265A, abstract, 206, 1992.
8. Virag, R., Shoukry, K., Floresco, J., Nollet, F. and Greco, E.: Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases. J. Urol., 145: 287, 1991.
9. Montorsi, F., Guazzoni, G., Bergamaschi, F., Dodesini, A., Rigatti, P., Pizzini, G. and Miani, A.: Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence. Urology, 42: 554, 1993.
10. Montorsi, F., Guazzoni, G., Bergamaschi, F., Ferini-strambi, L., Barbieri, L. and Rigatti, P.: Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction. J. Urol., 149: 1291, 1993.
11. Lopez-Mendonza, R., Tiso, G. and Amilachwri, B.: Five and six vasoactive drugs combination for diagnosis and treatment of impotence. Int. J. Impotence Res., suppl., 6: D1544., 1994.
12. Spiegel, M. R.: Estatistica, 3 ed. São Paulo, Makron Books do Brasil Editora Ltda, 258, 1993.
13. Sidi, A. A., Cameron, J. S., Duffy, L. M., and Lange, P. H.: Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients. J. Urol., 135: 704, 1986.
14. von Heyden, B., Donatucci, C. F., Kaula, N. and Lue, T. F.: Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. J. Urol., 149: 1288, 1993.
15. Girdley, F. M., Bruskewitz, R. C., Feyzi, J., Graversen, P. H. and Gasser, T. C.: Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients. J. Urol., 140: 972, 1988.
16. Slob, A. K., Rowland, D. L., Blom, J. H. and van der Werff ten Bosch, J. J.: Psychologic factors affect erectile response to papaverine. Urology, 38: 294, 1991.
17. Krane, R. J., Goldstein, I. and Saenz de Tejada, I.: Impotence. New Engl. J. Med., 321: 1648, 1989.
18. Donatucci, C. F. and Lue, T. F.: The combined intracavernous injection and stimulation test: diagnostic accuracy. J. Urol., 148: 61, 1992.
19. Floth, A. and Schramek, P.: Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone. J. Urol., 145: 56, 1991.
20. Bennet, A. H., Carpenter, A. J. and Barada, J. H.: An improved vasoactive drug combination for a pharmacological erection program. J. Urol., 146: 1564, 1991.
21. Govier, F. E., McClure, R. D., Weissman, R. M., Gibbons, R. P., Pritchett, T. R. and Kramer-Levien, D.: Experience with triple-drug therapy in a pharmacological erection program. J. Urol., 150: 1822, 1993.
22. Montorsi, F., Guazzoni, G., Bergamaschi, F., Zucconi, M., Rigatti, P., Pizzini, G., Miani, A. and Pozza, G.: Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence. Acta Diabetol., 31: 1, 1994.
23. Buvat, J., Buvat-Herbaut, M., Dehaene, J. L. and Lemaire, A.: Is intracavernous injection of papaverine a reliable screening test for vascular impotence? J. Urol., 135: 476, 1986.
24. Keogh, E. J.: Pharmacotherapy for impotence. Curr. Opin. Urol., 4: 336, 1994.
25. Strachan, J. R. and Pryor, J. P.: Diagnostic intracorporeal papaverine and erectile dysfunction, Brit. J. Urol., 59: 264, 1987.
26. McMahon, C. G.: The reability of the papaverine test as a screening test for vascular disease in impotence. Int. J. Impotence Res., 2: 133, 1990.
27. Lue, T. F. and Tanagho, E. A.: Hemodynamics of erection. In: Tanagho, E. A., Lue, T. F., McClure, R. D.: Contemporary management of impotence and infertility. Baltimore, Williams & Wilkins, chapt. 2, pp. 28, 1988.
28. Nellans, R. E., Ellis, L. R. and Kramer-Levien, D.: Pharmacological erection: diagnosis and treatment applications in 69 patients. J. Urol., 138: 52, 1987.
29. Stackl, W., Hasun, R. and Marberger, M.: Intracavernous injection of prostaglandin E1 in impotent men. J. Urol., 140: 66, 1988.
30. Hwang, T. I-S., Yang, C-R., Wang, S-J., Chang, C-L., Tzai, T-S., Chang, C-H. and Wu, H-C.: Impotence evaluated by the use of prostaglandin E1. J. Urol., 141: 1357, 1989.